Fecal Microbiota Transplant National Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorAmerican Gastroenterological Association
About this trial
A national data registry of patients receiving fecal microbiota transplantation (FMT) or other gut-related-microbiota products designed to prospectively assess short and long-term safety and effectiveness
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Recipient Inclusion Criteria
Ability to give informed consent
Receiving FMT or other gut-related microbiota product within 90 days after providing consent
Access to internet and/or telephone
Disqualifiers
Incarceration
Trial population
All patients receiving FMT or other gut-related-microbiota products and the donors providing specimens for the enrolled patients' FMT. Patients will be enrolled regardless of race, gender, ethnicity, or age.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
None - Observational
Other interventionNone - Observational
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Occurrence of treatment related Adverse Events
Adverse events to be monitored include surgeries, infection, hospitalization, other life-threatening events, death and newly diagnosed diseases.
Time frame
over 10 Years2
Disease Re-occurrence Following FMT
Assess effectiveness of FMT by monitoring disease re-occurrence post treatment.
Time frame
over 10 YearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
American Gastroenterological Association
Lead sponsor
OpenBiome
Collaborator
University of California, San Diego
Collaborator
University of Pennsylvania
Collaborator
University of Minnesota
Collaborator
Loyola University Chicago
Collaborator
Commure, Inc
Collaborator
Source ClinicalTrials.gov